BR9908991A - Composições de paroxetina - Google Patents

Composições de paroxetina

Info

Publication number
BR9908991A
BR9908991A BR9908991-2A BR9908991A BR9908991A BR 9908991 A BR9908991 A BR 9908991A BR 9908991 A BR9908991 A BR 9908991A BR 9908991 A BR9908991 A BR 9908991A
Authority
BR
Brazil
Prior art keywords
paroxetine
compositions
therapy
vehicle
adsorbed onto
Prior art date
Application number
BR9908991-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew Simon Craig
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9908991A publication Critical patent/BR9908991A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9908991-2A 1998-03-24 1999-03-24 Composições de paroxetina BR9908991A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Publications (1)

Publication Number Publication Date
BR9908991A true BR9908991A (pt) 2000-12-12

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908991-2A BR9908991A (pt) 1998-03-24 1999-03-24 Composições de paroxetina

Country Status (20)

Country Link
EP (1) EP1063993A1 (ja)
JP (1) JP2002507569A (ja)
CN (1) CN1125639C (ja)
AP (1) AP2000001914A0 (ja)
AU (1) AU754765B2 (ja)
BG (1) BG104865A (ja)
BR (1) BR9908991A (ja)
CA (1) CA2324612A1 (ja)
EA (1) EA003393B1 (ja)
GB (1) GB9806312D0 (ja)
HU (1) HUP0101326A3 (ja)
ID (1) ID26485A (ja)
IL (1) IL138478A0 (ja)
NO (1) NO313404B1 (ja)
NZ (1) NZ506893A (ja)
PL (1) PL343095A1 (ja)
SK (1) SK14102000A3 (ja)
TR (1) TR200002750T2 (ja)
WO (1) WO1999048499A1 (ja)
ZA (1) ZA200005697B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
WO2005002541A2 (en) * 2003-07-02 2005-01-13 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
NO20004740L (no) 2000-10-03
CA2324612A1 (en) 1999-09-30
ID26485A (id) 2001-01-11
SK14102000A3 (sk) 2001-03-12
IL138478A0 (en) 2001-10-31
WO1999048499A1 (en) 1999-09-30
HUP0101326A2 (hu) 2002-05-29
PL343095A1 (en) 2001-07-30
AP2000001914A0 (en) 2000-09-30
HUP0101326A3 (en) 2002-06-28
EA200000977A1 (ru) 2001-02-26
CN1294512A (zh) 2001-05-09
JP2002507569A (ja) 2002-03-12
ZA200005697B (en) 2001-10-02
GB9806312D0 (en) 1998-05-20
NO20004740D0 (no) 2000-09-22
NO313404B1 (no) 2002-09-30
AU754765B2 (en) 2002-11-21
NZ506893A (en) 2003-06-30
EA003393B1 (ru) 2003-04-24
TR200002750T2 (tr) 2000-12-21
AU3045199A (en) 1999-10-18
EP1063993A1 (en) 2001-01-03
BG104865A (en) 2001-05-31
CN1125639C (zh) 2003-10-29

Similar Documents

Publication Publication Date Title
PL342162A1 (en) Galenic form for oral administration of either immediate or prolonged drug release containing an absorption enhancing agent and application of such absorption enhancing agent
SE9700135D0 (sv) New formulation
HUP0104696A3 (en) Pharmaceutical composition containing 5ht1 receptor agonists and metoclopramide for the treatment of migraine
HUP0301194A3 (en) Pharmaceutical compositions containing combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents and their use for the treatment of diabete mellitus
FR2786075B1 (fr) Conditionnement etanche pour compositions cosmetiques et/ou pharmaceutiques
NZ510384A (en) Sustained release ranolazine formulations
PL339541A1 (en) Application of combinations containing non-calming antihistaminic agents and alpha-adrenergic drug in locally treating rhinitis/ophtalmitis as well as cold and cold symptoms and/or influenza
SI1553927T1 (sl) Z gelom stabilizirani nanodeläśni sestavki uäśinkovine
MA26882A1 (fr) COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
GB2349819A (en) Compositions for the treatment of skin and anorectal conditions
HK1134025A1 (en) Compositions and kits for enhancing delivery of therapeutic agents to cells
HUP0003133A2 (en) Ace-inhibitor nitric salts and use of them for producing pharmaceutical compositions
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
SE9700134D0 (sv) New formulation
SE9700133D0 (sv) New formulation
BR9908991A (pt) Composições de paroxetina
TR200002507T2 (tr) Ateş basmasını azaltmak için fluoksetin hidroklorür
RS49703B (sr) Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba
PL356780A1 (en) Novel compounds
MY132978A (en) Pharmaceutical compositions containing micronized bicyclic drugs
DE69909128D1 (de) Einschlusskomplexe von dehydroepiandrosteron und korrespondierende pharmazeutische zusammenstellungen
SE9700136D0 (sv) New formulation
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
ES2191625T3 (es) Composicion oral que contiene perlita.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1914 DE 11/09/2007.